F-STAR THERAPEUTICS INC's ticker is FSTX and the CUSIP is 30315R107. A total of 44 filers reported holding F-STAR THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 3.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $15,000 | -31.8% | 2,424 | -42.6% | 0.00% | – |
| Q3 2022 | $22,000 | -29.0% | 4,225 | -14.6% | 0.00% | – |
| Q2 2022 | $31,000 | +106.7% | 4,946 | +14.3% | 0.00% | – |
| Q1 2022 | $15,000 | +200.0% | 4,327 | +312.5% | 0.00% | – |
| Q4 2021 | $5,000 | -37.5% | 1,049 | +2.0% | 0.00% | – |
| Q3 2021 | $8,000 | +33.3% | 1,028 | +39.3% | 0.00% | – |
| Q2 2021 | $6,000 | +20.0% | 738 | +77.0% | 0.00% | – |
| Q1 2021 | $5,000 | +66.7% | 417 | +64.2% | 0.00% | – |
| Q4 2020 | $3,000 | – | 254 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ridgeback Capital Investments L.P. | 1,834,360 | $9,208,000 | 5.02% |
| DAFNA Capital Management LLC | 693,785 | $3,483,000 | 0.88% |
| Atlas Venture Advisors, Inc. | 574,996 | $2,886,000 | 0.40% |
| Atlas Venture Life Science Advisors, LLC | 599,524 | $3,010,000 | 0.28% |
| Anson Funds Management LP | 309,703 | $1,555,000 | 0.15% |
| Connolly Sarah T. | 53,001 | $266,000 | 0.15% |
| Rock Springs Capital Management LP | 751,889 | $3,774,000 | 0.09% |
| Point72 Asset Management, L.P. | 981,249 | $4,926,000 | 0.02% |
| Eversept Partners, LP | 49,933 | $250,664 | 0.02% |
| Private Capital Advisors, Inc. | 13,083 | $66,000 | 0.01% |